A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients.

Oluwaseun ShogbesanDilli Ram PoudelSamjeris VictorAsad JehangirOpeyemi FadahunsiGbenga ShogbesanAnthony A Donato

Published in: Canadian journal of gastroenterology & hepatology (2018)

We found evidence that supports the use of FMT for treatment of CD infection in immunocompromised patients, with similar rates of serious adverse events to immunocompetent patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
intensive care unit
acute respiratory distress syndrome
extracorporeal membrane oxygenation
smoking cessation
mechanical ventilation